drugset / Trial / NCT05155969
Intravenous Esketamine on Prevention of Postoperative Depression in Patients Undergoing Cardiac Surgery
RandomizedParallel-groupQuadruple-blindPrevention
Summary
Esketamine is a general anesthetic with anti-depressant effects at subanaesthetic doses. This study hypothesized that intraoperative administration of ketamine would prevent or mitigate postoperative depressive symptoms in surgical patients.
Timeline
- Start
- 2021-12-01
- Primary completion
- 2021-12-05
- Completion
- 2022-12-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Esketamine | Other / unclassified | 0.3 mg/kg | Intravenous |
Indications
No indication recorded.